Switzerland 1977, Dr. Andreas Grüntzig performed the worldwide first balloon dilatation of a coronary artery to treat coronary artery disease. He used a balloon catheter that was developed in close collaboration with engineers and clinicians. Our mission is to carry on this tradition and spirit leading to the development of innovative cardiovascular devices and treatment techniques.
ARTORG Cardiovascular Engineering (ACE) is a joint technological-clinical research organization that is part of the newly founded Artificial Organ (ARTORG) Center for Biomedical Engineering Research at the University of Bern. The clinical partners of ACE are found in the Departments of Cardiovascular Surgery and Cardiology (Inselspital, University Hospital Bern) and the Medical Faculty of the University of Bern. ACE converges expertise in biomedical engineering research, clinical research and clinical medicine in search of novel solutions for the diagnostic and therapeutic management of cardiovascular diseases. With the patient in the focus, our dedicated vision is to improve cardiovascular care by education, development, application and evaluation. To achieve this, joint ventures are formed and services rendered to lead to continuous translation of new technologies to clinical practice.
ACE is co-directed by two experienced researchers with strong technological and clinical background, respectively, and has well established collaborative links to internal and external institutes covering the broad spectrum of multi-disciplinary research activities. ACE is well integrated into the medical technology industry network worldwide and in Switzerland, ensuring a direct path to the realization of our research goals.